- Home
- SUPN vs WKC Comparison
SUPN vs WKC Comparison
Compare SUPN & WKC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- WKC
- Stock Information
- Founded
- SUPN 2005
- WKC 1984
- Country
- SUPN United States
- WKC United States
- Employees
- SUPN N/A
- WKC N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- WKC Oil Refining/Marketing
- Sector
- SUPN Health Care
- WKC Energy
- Exchange
- SUPN Nasdaq
- WKC Nasdaq
- Market Cap
- SUPN 1.8B
- WKC 1.5B
- IPO Year
- SUPN 2012
- WKC N/A
- Fundamental
- Price
- SUPN $31.91
- WKC $27.53
- Analyst Decision
- SUPN Hold
- WKC Sell
- Analyst Count
- SUPN 2
- WKC 4
- Target Price
- SUPN $36.00
- WKC $29.00
- AVG Volume (30 Days)
- SUPN 460.6K
- WKC 586.2K
- Earning Date
- SUPN 05-06-2025
- WKC 07-24-2025
- Dividend Yield
- SUPN N/A
- WKC 2.48%
- EPS Growth
- SUPN N/A
- WKC N/A
- EPS
- SUPN 1.11
- WKC 0.32
- Revenue
- SUPN $667,997,000.00
- WKC $40,669,100,000.00
- Revenue This Year
- SUPN N/A
- WKC N/A
- Revenue Next Year
- SUPN $8.74
- WKC $5.20
- P/E Ratio
- SUPN $28.64
- WKC $84.38
- Revenue Growth
- SUPN 11.82
- WKC N/A
- 52 Week Low
- SUPN $25.53
- WKC $22.71
- 52 Week High
- SUPN $40.28
- WKC $31.71
- Technical
- Relative Strength Index (RSI)
- SUPN 47.71
- WKC 57.35
- Support Level
- SUPN $31.56
- WKC $26.68
- Resistance Level
- SUPN $32.85
- WKC $28.00
- Average True Range (ATR)
- SUPN 0.78
- WKC 0.47
- MACD
- SUPN -0.08
- WKC -0.00
- Stochastic Oscillator
- SUPN 24.38
- WKC 64.02
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About WKC World Kinect Corporation
World Kinect Corp is an energy management company involved in providing supply fulfillment, energy procurement advisory services, and transaction and payment management solutions to commercial and industrial customers. It sells and delivers liquid fuels, natural gas, electricity, renewable energy, and other sustainability solutions. The company operates in three reportable segments consisting of aviation, land, and marine. The company earns the majority of its revenue from the Aviation segment.